keyword
https://read.qxmd.com/read/38822147/motor-and-non-motor-outcome-in-tremor-dominant-parkinson-s-disease-after-mr-guided-focused-ultrasound-thalamotomy
#41
JOURNAL ARTICLE
Veronika Purrer, Emily Pohl, Valeri Borger, Hannah Weiland, Henning Boecker, Frederic Carsten Schmeel, Ullrich Wüllner
BACKGROUND AND OBJECTIVES: Magnetic Resonance-guided Focused Ultrasound (MRgFUS) is an emerging technique for the treatment of severe, medication-refractory tremor syndromes. We here report motor and non-motor outcomes 6 and 12 months after unilateral MRgFUS thalamotomy in tremor-dominant Parkinson's disease (tdPD). METHODS: 25 patients with tdPD underwent neuropsychological evaluation including standardized questionnaires of disability, quality of life (QoL), mood, anxiety, apathy, sleep disturbances, and cognition at baseline, 6 and 12 months after MRgFUS...
May 31, 2024: Journal of Neurology
https://read.qxmd.com/read/38822123/association-between-voriconazole-induced-visual-hallucination-and-dopamine-in-an-analysis-of-the-food-and-drug-administration-fda-adverse-event-reporting-system-database
#42
JOURNAL ARTICLE
Hideo Kato, Chihiro Shiraishi, Mao Hagihara, Hiroshige Mikamo, Takuya Iwamoto
Voriconazole is a second-generation azole used to treat serious fungal infections. Visual hallucinations constitute a representative adverse event caused by voriconazole. However, its mechanism of action remains unclear. In patients with schizophrenia or Parkinson's disease, the frequency of visual hallucinations is associated with brain dopamine levels. This study investigated the frequency of visual hallucinations in patients treated with voriconazole alone or in combination with dopaminergic medicines or dopamine antagonists, using data collected from the Food and Drug Administration Adverse event Reporting System (FAERS)...
May 31, 2024: Scientific Reports
https://read.qxmd.com/read/38821932/aplp1-interacts-with-lag3-to-facilitate-transmission-of-pathologic-%C3%AE-synuclein
#43
JOURNAL ARTICLE
Xiaobo Mao, Hao Gu, Donghoon Kim, Yasuyoshi Kimura, Ning Wang, Enquan Xu, Ramhari Kumbhar, Xiaotian Ming, Haibo Wang, Chan Chen, Shengnan Zhang, Chunyu Jia, Yuqing Liu, Hetao Bian, Senthilkumar S Karuppagounder, Fatih Akkentli, Qi Chen, Longgang Jia, Heehong Hwang, Su Hyun Lee, Xiyu Ke, Michael Chang, Amanda Li, Jun Yang, Cyrus Rastegar, Manjari Sriparna, Preston Ge, Saurav Brahmachari, Sangjune Kim, Shu Zhang, Yasushi Shimoda, Martina Saar, Haiqing Liu, Sin Ho Kweon, Mingyao Ying, Creg J Workman, Dario A A Vignali, Ulrike C Muller, Cong Liu, Han Seok Ko, Valina L Dawson, Ted M Dawson
Pathologic α-synuclein (α-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid β precursor-like protein 1 (Aplp1) interacts with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic α-syn. Deletion of both Aplp1 and Lag3 eliminates the loss of dopaminergic neurons and the accompanying behavioral deficits induced by α-syn preformed fibrils (PFF). Anti-Lag3 prevents the internalization of α-syn PFF by disrupting the interaction of Aplp1 and Lag3, and blocks the neurodegeneration induced by α-syn PFF in vivo...
May 31, 2024: Nature Communications
https://read.qxmd.com/read/38821913/deep-brain-stimulation-of-symptom-specific-networks-in-parkinson-s-disease
#44
MULTICENTER STUDY
Nanditha Rajamani, Helen Friedrich, Konstantin Butenko, Till Dembek, Florian Lange, Pavel Navrátil, Patricia Zvarova, Barbara Hollunder, Rob M A de Bie, Vincent J J Odekerken, Jens Volkmann, Xin Xu, Zhipei Ling, Chen Yao, Petra Ritter, Wolf-Julian Neumann, Georgios P Skandalakis, Spyridon Komaitis, Aristotelis Kalyvas, Christos Koutsarnakis, George Stranjalis, Michael Barbe, Vanessa Milanese, Michael D Fox, Andrea A Kühn, Erik Middlebrooks, Ningfei Li, Martin Reich, Clemens Neudorfer, Andreas Horn
Deep Brain Stimulation can improve tremor, bradykinesia, rigidity, and axial symptoms in patients with Parkinson's disease. Potentially, improving each symptom may require stimulation of different white matter tracts. Here, we study a large cohort of patients (N = 237 from five centers) to identify tracts associated with improvements in each of the four symptom domains. Tremor improvements were associated with stimulation of tracts connected to primary motor cortex and cerebellum. In contrast, axial symptoms are associated with stimulation of tracts connected to the supplementary motor cortex and brainstem...
May 31, 2024: Nature Communications
https://read.qxmd.com/read/38821395/electrophysiological-sweet-spot-mapping-in-deep-brain-stimulation-for-parkinson-s-disease-patients
#45
JOURNAL ARTICLE
Jana Peeters, Tine Van Bogaert, Alexandra Boogers, Robin Gransier, Jan Wouters, Philippe De Vloo, Wim Vandenberghe, Michael T Barbe, Veerle Visser-Vandewalle, Bart Nuttin, Till A Dembek, Myles Mc Laughlin
BACKGROUND: Subthalamic deep brain stimulation (STN-DBS) is a well-established therapy to treat Parkinson's disease (PD). However, the STN-DBS sub-target remains debated. Recently, a white matter tract termed the hyperdirect pathway (HDP), directly connecting the motor cortex to STN, has gained interest as HDP stimulation is hypothesized to drive DBS therapeutic effects. Previously, we have investigated EEG-based evoked potentials (EPs) to better understand the neuroanatomical origins of the DBS clinical effect...
May 29, 2024: Brain Stimulation
https://read.qxmd.com/read/38821163/17-%C3%AE-estradiol-potentiates-the-neurotrophic-and-neuroprotective-effects-mediated-by-the-dopamine-d3-acetylcholine-nicotinic-receptor-heteromer-in-dopaminergic-neurons
#46
JOURNAL ARTICLE
Giulia Sbrini, Veronica Mutti, Federica Bono, Zaira Tomasoni, Dounia Fadel, Cristina Missale, Chiara Fiorentini
Dopaminergic neurons express an heteromer composed of the dopamine D3 receptor and the α4-β2 nicotinic acetylcholine receptor, the D3R-nAChR heteromer, activated by both nicotine and dopamine D2 and D3 receptors agonists, such as quinpirole, and crucial for dopaminergic neuron homeostasis. We now report that D3R-nAChR heteromer activity is potentiated by 17-β-estradiol which acts as a positive allosteric modulator by binding a specific domain on the α4 subunit of the nicotinic receptor protomer...
May 29, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38820865/generation-of-an-ipsc-line-from-a-79-year-old-female-patient-diagnosed-with-sporadic-parkinson-s-disease
#47
JOURNAL ARTICLE
Jingrui Liu, Juan Du, Xiaowei Ma, Yuchuan Jin, Qian Yang, Yingtong Zhai, Jingke Cheng, Feng Luan, Min Ma, Zhanchi Zhang, Qian Ren, Huixian Cui
Parkinson's disease is a common neurodegenerative disorder. Here we present a human induced pluripotent stem cells (iPSCs) derived from peripheral blood mononuclear cells (PBMCs) of a 79-year-old female patient diagnosed with sporadic Parkinson's disease using the sendai virus. Generated iPSCs maintain normal karyotype, exhibit pluripotent stem cell markers, and possess differentiation potential. The iPSCs allows for differentiation into various cell subtypes, providing conditions for the research of the pathogenesis and drug development of Parkinson's disease...
May 22, 2024: Stem Cell Research
https://read.qxmd.com/read/38820057/employer-representatives-experiences-of-supporting-employees-with-cognitive-impairments-in-a-digital-work-environment
#48
JOURNAL ARTICLE
Monika Lindberg, Maria Larsson-Lund, Anna Berg Jansson, Maria Ranner
BACKGROUND: Digital work poses cognitive demands on all employees, but the impact is greater for employees with cognitive impairments. Digitalization also has significant implications for employer representatives as they are responsible for the work environment. However, knowledge is scarce concerning employer representatives' perspectives on identifying needs and support for employees with cognitive impairments working in a digital work environment. OBJECTIVE: To describe employer representatives' experiences of work environment management with focus on employees with cognitive impairments working in a digital environment...
May 29, 2024: Work: a Journal of Prevention, Assessment, and Rehabilitation
https://read.qxmd.com/read/38820022/localized-pantothenic-acid-vitamin-b5-reductions-present-throughout-the-dementia-with-lewy-bodies-brain
#49
JOURNAL ARTICLE
Melissa Scholefield, Stephanie J Church, Jingshu Xu, Stefano Patassini, Garth J S Cooper
BACKGROUND: Localized pantothenic acid deficiencies have been observed in several neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease dementia (PDD), and Huntington's disease (HD), indicating downstream energetic pathway perturbations. However, no studies have yet been performed to see whether such deficiencies occur across the dementia with Lewy bodies (DLB) brain, or what the pattern of such dysregulation may be. OBJECTIVE: Firstly, this study aimed to quantify pantothenic acid levels across ten regions of the brain in order to determine the localization of any pantothenic acid dysregulation in DLB...
May 24, 2024: Journal of Parkinson's Disease
https://read.qxmd.com/read/38820021/occupational-pesticide-exposure-in-parkinson-s-disease-related-to-gba-and-lrrk2-variants
#50
JOURNAL ARTICLE
Ethan G Brown, Samuel M Goldman, Christopher S Coffey, Andrew Siderowf, Tanya Simuni, Cheryl Meng, Michael C Brumm, Chelsea Caspell-Garcia, Kenneth Marek, Caroline M Tanner
BACKGROUND: The penetrance of common genetic risk variants for Parkinson's disease (PD) is low. Pesticide exposure increases PD risk, but how exposure affects penetrance is not well understood. OBJECTIVE: To determine the relationship between occupational pesticide exposure and PD in people with LRRK2 and GBA risk variants. METHODS: Participants of the Parkinson's Progression Markers Initiative (PPMI) with a LRRK2-G2019 S or GBA risk variant provided information about occupational pesticide exposure...
May 28, 2024: Journal of Parkinson's Disease
https://read.qxmd.com/read/38819635/resveratrol-inhibits-vdac1-mediated-mitochondrial-dysfunction-to-mitigate-pathological-progression-in-parkinson-s-disease-model
#51
JOURNAL ARTICLE
Shenglan Feng, Jianjun Gui, Bingqing Qin, Junjie Ye, Qiang Zhao, Ai Guo, Ming Sang, Xiaodong Sun
An increase in α-synuclein (α-syn) levels and mutations in proteins associated with mitochondria contribute to the development of familial Parkinson's disease (PD); however, the involvement of α-syn and mitochondria in idiopathic PD remains incompletely understood. The voltage-dependent anion channel I (VDAC1) protein, which serves as a crucial regulator of mitochondrial function and a gatekeeper, plays a pivotal role in governing cellular destiny through the control of ion and respiratory metabolite flux...
May 31, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38819491/new-insights-into-sodium-phenylbutyrate-as-a-pharmacotherapeutic-option-for-neurological-disorders
#52
REVIEW
Daniel Juarez, Anabella Handal-Silva, Jose Luis Morán-Perales, Diana M Torres-Cifuentes, Gonzalo Flores, Samuel Treviño, Albino Moreno-Rodriguez, Jorge Guevara, Alfonso Diaz
Neurological disorders (NDs) are diseases of the central and peripheral nervous systems that affect more than one billion people worldwide. The risk of developing an ND increases with age due to the vulnerability of the different organs and systems to genetic, environmental, and social changes that consequently cause motor and cognitive deficits that disable the person from their daily activities and individual and social productivity. Intrinsic factors (genetic factors, age, gender) and extrinsic factors (addictions, infections, or lifestyle) favor the persistence of systemic inflammatory processes that contribute to the evolution of NDs...
July 2024: Synapse
https://read.qxmd.com/read/38819068/additive-neurorestorative-effects-of-exercise-and-docosahexaenoic-acid-intake-in-a-mouse-model-of-parkinson-s-disease
#53
JOURNAL ARTICLE
Olivier Kerdiles, Méryl-Farelle Oye Mintsa Mi-Mba, Katherine Coulombe, Cyntia Tremblay, Vincent Émond, Martine Saint-Pierre, Clémence Rouxel, Line Berthiaume, Pierre Julien, Francesca Cicchetti, Frédéric Calon
JOURNAL/nrgr/04.03/01300535-202502000-00033/figure1/v/2024-05-28T214302Z/r/image-tiff There is a need to develop interventions to slow or reverse the degeneration of dopamine neurons in Parkinson's disease after diagnosis. Given that preclinical and clinical studies suggest benefits of dietary n-3 polyunsaturated fatty acids, such as docosahexaenoic acid, and exercise in Parkinson's disease, we investigated whether both could synergistically interact to induce recovery of the dopaminergic pathway. First, mice received a unilateral stereotactic injection of 6-hydroxydopamine into the striatum to establish an animal model of nigrostriatal denervation...
February 1, 2025: Neural Regeneration Research
https://read.qxmd.com/read/38819059/movement-analysis-in-the-diagnosis-and-management-of-parkinson-s-disease
#54
JOURNAL ARTICLE
Johannes Burtscher, Nicolas Bourdillon, Jules M Janssen Daalen, Aurélien Patoz, Julien F Bally, Martin Kopp, Davide Malatesta, Bastiaan R Bloem
No abstract text is available yet for this article.
February 1, 2025: Neural Regeneration Research
https://read.qxmd.com/read/38818769/the-effects-of-myofascial-release-in-combined-with-task-oriented-circuit-training-on-balance-in-people-with-parkinson-s-disease-a-randomized-pilot-trial
#55
JOURNAL ARTICLE
Kutay Kaşlı, Mert Doğan, Cemil Özal, Yahya Doğan, Muhammed Kılınç, Sibel Aksu Yıldırım
OBJECTIVES: Task-oriented circuit training (TOCT) has been used to improve balance in people with Parkinson's disease (pwPD). To investigate the effectiveness of TOCT on balance, quality of life, and disease symptoms when combined with myofascial release in pwPD. METHODS: Twenty-six pwPD were randomized into two groups for this randomized controlled study. The groups received TOCT three days a week for eight weeks. At the end of each session, the myofascial release was applied to the neck, trunk, and lumbar region with three sets of 60-s foam rolling body weight (Intervention group-IG) and perceived discomfort level 0/10 (Control group-CG) using a numeric rating scale...
May 31, 2024: Neurological Research
https://read.qxmd.com/read/38818615/computational-insights-into-chromene-pyran-derivatives-molecular-docking-admet-studies-dft-calculations-and-md-simulations-as-promising-candidates-for-parkinson-s-disease
#56
JOURNAL ARTICLE
Anjali Rani, Mohd Aslam, Javed Khan, Garima Pandey, Prashant Singh, R S Maharia, Bhaskara Nand Pant
Parkinson's disease (PD) is a neurodegenerative condition characterized by both motor and non-motor symptoms. Although PD is commonly associated with a decline of dopaminergic neurons in the substantia nigra, other diagnostic criteria and biomarkers also exist. In the search for novel therapeutic agents, chromene and pyran derivatives have shown potential due to their diverse pharmacological activities. This study utilizes a comprehensive computational approach to investigate the viability of chromene/pyran compounds as potential treatments for PD...
May 31, 2024: Chemistry & Biodiversity
https://read.qxmd.com/read/38818523/potential-molecular-mechanism-of-exercise-reversing-insulin-resistance-and-improving-neurodegenerative-diseases
#57
REVIEW
Jiawen Shen, Xianping Wang, Minghui Wang, Hu Zhang
Neurodegenerative diseases are debilitating nervous system disorders attributed to various conditions such as body aging, gene mutations, genetic factors, and immune system disorders. Prominent neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and multiple sclerosis. Insulin resistance refers to the inability of the peripheral and central tissues of the body to respond to insulin and effectively regulate blood sugar levels. Insulin resistance has been observed in various neurodegenerative diseases and has been suggested to induce the occurrence, development, and exacerbation of neurodegenerative diseases...
2024: Frontiers in Physiology
https://read.qxmd.com/read/38817911/case-report-early-onset-parkinson-s-disease-with-lower-limb-spasticity-in-a-new-dj-1-park7-patient
#58
Masako Fujita, Haruo Nishijima, Atsuko Katagai, Chieko Suzuki, Nobutaka Hattori, Masahiko Tomiyama
Rare autosomal recessive variants in DJ-1 , a causative gene for early-onset Parkinson's disease, have been associated with a variety of clinical syndromes in a limited number of patients. Here, we report a case of a novel DJ-1 variant in a 39-year-old man with a 4-year history of parkinsonism, cognitive dysfunction, and lower limb spasticity. He was diagnosed with Parkinson's disease. Genetic testing of the patient revealed compound heterozygous variants in the DJ-1 gene (exon 6 deletion + c...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38817910/pink1-knockout-rats-show-premotor-cognitive-deficits-measured-through-a-complex-maze
#59
JOURNAL ARTICLE
Isabel Soto, Vicki A Nejtek, David P Siderovski, Michael F Salvatore
Cognitive decline in Parkinson's disease (PD) is a critical premotor sign that may occur in approximately 40% of PD patients up to 10 years prior to clinical recognition and diagnosis. Delineating the mechanisms and specific behavioral signs of cognitive decline associated with PD prior to motor impairment is a critical unmet need. Rodent PD models that have an impairment in a cognitive phenotype for a time period sufficiently long enough prior to motor decline can be useful to establish viable candidate mechanisms...
2024: Frontiers in Neuroscience
https://read.qxmd.com/read/38817725/standardization-and-clinical-use-of-a-single-vial-formulation-of-technetium-99m-trodat-using-autoclave-method
#60
JOURNAL ARTICLE
Riptee Thakur, Chandana Nagaraj, Raman Kumar Joshi, Jitender Saini, Ravi Yadav, Pardeep Kumar
BACKGROUND: Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra. SPECT imaging using technetium-99m [99m Tc] labeled trodat is the choice of imaging to differentiate PD from its other forms like drug-induced PD. AIMS AND OBJECTIVES: The main objective of our study was to prepare in-house sterile formulation of [99m Tc]Tc-trodat and use in clinics. MATERIALS AND METHODS: The labeling of trodat was standardized using glucoheptonate sodium salt (GHA), stannous chloride dihydrate (in 0...
2024: Indian Journal of Nuclear Medicine: IJNM: the Official Journal of the Society of Nuclear Medicine, India
keyword
keyword
44211
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.